scieee Science in your language
[en] (orig)

Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: A randomised clinical trial protocol

Abstract

Introduction Major depression is a highly prevalent pathology that is currently the second most common cause of disease-induced disability in our society. The onset and continuation of depression may be related to a wide variety of biological and psychosocial factors, many of which are linked to different lifestyle aspects. Therefore, health systems must design and implement health promotion and lifestyle modification programmes (LMPs), taking into account personal factors and facilitators. The main objective of this protocol is to analyse the clinical effectiveness, cost-effectiveness and cost utility of an LMP and an LMP with information and communication technologies (ICTs) as adjunctive treatment for depression in primary care patients. The secondary objectives are to analyse the clinical effectiveness in the subgroup that presents comorbidity and to analyse the correlation between personal factors on health behaviour and lifestyle patterns. Methods and analysis A randomised, multicenter pragmatic clinical trial with three parallel groups consisting of primary healthcare patients suffering from subclinical, mild or moderate depression. The following interventions will be used: (1) Usual antidepressant treatment with psychological advice and/or psychotropic drugs prescribed by the general practitioner (treatment as usual (TAU)). (2) TAU+LMP. A programme to be imparted in six weekly 90-minute group sessions, intended to improve the following aspects: behavioural activation+daily physical activity+adherence to the Mediterranean diet pattern+sleep hygiene+careful exposure to sunlight. (3) TAU+LMP+ICTs: healthy lifestyle recommendations (TAU+LMP)+monitoring using ICTs (a wearable smartwatch). The primary outcome will be the depressive symptomatology and the secondary outcomes will be the quality of life, the use of health and social resources, personal factors on health behaviour, social support, lifestyle patterns and chronic comorbid pathology. Data will be collected before and after the intervention, with 6-month and 12-month follow-ups. Ethics and dissemination This study has been approved by the Clinical Research Ethics Committee of Aragón (approval number: C.P.-C.I. PI18/286) and the Research Ethics Committee of the Balearic Islands (IB3950/19 PI). Data distribution will be anonymous. Results will be disseminated via conferences and papers published in peer-reviewed, open-access journals. Trial registration number ClinicalTrials.gov Registry (NCT03951350). Aguilar-Latorre, A.; Navarro, C.; Oliván-Blázquez, B.; Gervilla, E.; Magallón Botaya, R.; Calafat-Villalonga, C.; García-Toro, M.; Boira, S.; Serrano-Ripoll, M.J.

Read accessible full text

Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: A randomised clinical trial protocol

Author: Aguilar-Latorre, A.; Calafat-Villalonga, C.; Oliván-Blázquez, B.; Boira, S.; Magallón Botaya, R.; Navarro, C.; García-Toro, M.; Gervilla, E.; Serrano-Ripoll, M.J.
Year: 2020
DOI: 10.1136/bmjopen-2020-038457
Source: https://zaguan.unizar.es/record/99066/files/texto_completo.pdf
1
Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
E ec i eness and cos - e ec i eness o a
li es yle modi ica ion p og amme in he
p e en ion and ea men o subclinical,
mild and mode a e dep ession in
p ima y ca e: a andomised clinical
ial p o ocol
Alejand a Aguila - La o e ,1 Capilla Na a o,2 Bá ba a Oli án- Blázquez,1,3
Elena Ge illa,2,4 Rosa Magallón Bo aya,1,5 Ca alina Cala a - Villalonga,2
Mau o Ga cía- To o,6,7 San iago Boi a,3 Ma ía Jesús Se ano- Ripoll2,8
To ci e: Aguila - La o eA,
Na a oC, Oli án- BlázquezB,
e al. E ec i eness and cos -
e ec i eness o a li es yle
modi ica ion p og amme in
he p e en ion and ea men
o subclinical, mild and
mode a e dep ession in p ima y
ca e: a andomised clinical
ial p o ocol. BMJ Open
2020;10:e038457. doi:10.1136/
bmjopen-2020-038457
►P epublica ion his o y and
addi ional ma e ials o his
pape a e a ailable online. To
iew hese iles, please isi
he jou nal online (h p:// dx. doi.
o g/ 10. 1136/ bmjopen- 2020-
038457).
Recei ed 11 Ma ch 2020
Re ised 19 Oc obe 2020
Accep ed 19 No embe 2020
Fo numbe ed a ilia ions see
end o a icle.
Co espondence o
D Bá ba a Oli án- Blázquez;
ba ba aoli an@ gmail. com
P o ocol
© Au ho (s) (o hei
employe (s)) 2020. Re- use
pe mi ed unde CC BY- NC. No
comme cial e- use. See igh s
and pe missions. Published by
BMJ.
ABSTRACT
In oduc ion Majo dep ession is a highly p e alen
pa hology ha is cu en ly he second mos common
cause o disease- induced disabili y in ou socie y. The
onse and con inua ion o dep ession may be ela ed o a
wide a ie y o biological and psychosocial ac o s, many
o which a e linked o di e en li es yle aspec s. The e o e,
heal h sys ems mus design and implemen heal h
p omo ion and li es yle modi ica ion p og ammes (LMPs),
aking in o accoun pe sonal ac o s and acili a o s. The
main objec i e o his p o ocol is o analyse he clinical
e ec i eness, cos - e ec i eness and cos u ili y o an
LMP and an LMP wi h in o ma ion and communica ion
echnologies (ICTs) as adjunc i e ea men o dep ession
in p ima y ca e pa ien s. The seconda y objec i es a e
o analyse he clinical e ec i eness in he subg oup
ha p esen s como bidi y and o analyse he co ela ion
be ween pe sonal ac o s on heal h beha iou and li es yle
pa e ns.
Me hods and analysis A andomised, mul icen e
p agma ic clinical ial wi h h ee pa allel g oups
consis ing o p ima y heal hca e pa ien s su e ing om
subclinical, mild o mode a e dep ession. The ollowing
in e en ions will be used: (1) Usual an idep essan
ea men wi h psychological ad ice and/o psycho opic
d ugs p esc ibed by he gene al p ac i ione ( ea men as
usual (TAU)). (2) TAU+LMP. A p og amme o be impa ed in
six weekly 90- minu e g oup sessions, in ended o imp o e
he ollowing aspec s: beha iou al ac i a ion+daily
physical ac i i y+adhe ence o he Medi e anean die
pa e n+sleep hygiene+ca e ul exposu e o sunligh .
(3) TAU+LMP+ICTs: heal hy li es yle ecommenda ions
(TAU+LMP)+moni o ing using ICTs (a wea able
sma wa ch). The p ima y ou come will be he dep essi e
symp oma ology and he seconda y ou comes will be
he quali y o li e, he use o heal h and social esou ces,
pe sonal ac o s on heal h beha iou , social suppo ,
li es yle pa e ns and ch onic como bid pa hology. Da a
will be collec ed be o e and a e he in e en ion, wi h
6- mon h and 12- mon h ollow- ups.
E hics and dissemina ion This s udy has been app o ed
by he Clinical Resea ch E hics Commi ee o A agón
(app o al numbe : C.P.-C.I. PI18/286) and he Resea ch
E hics Commi ee o he Balea ic Islands (IB3950/19
PI). Da a dis ibu ion will be anonymous. Resul s will be
dissemina ed ia con e ences and pape s published in
pee - e iewed, open- access jou nals.
T ial egis a ion numbe ClinicalT ials. go Regis y
(NCT03951350).
INTRODUCTION
Dep ession is conside ed o be he p inciple
cause o disabili y wo ldwide, and i con ib-
u es o he o e all global bu den o mo bidi y
and mo ali y. By 2030, i is expec ed o
be he main con ibu o o he bu den o
mo bidi y.1–3 App oxima ely 25%–35% o all
p ima y ca e pa ien s su e om psychia ic
diso de s, and o e 80% o hese pa ien s
su e om dep ession o anxie y diso -
de s.4 5 In Spanish p ima y heal hca e cen es
S eng hs and limi a ions o his s udy
►The in e en ion has he po en ial o be highly scal-
able and sus ainable o he Spanish Na ional Heal h
Se ice.
►Inc eased mo i a ion, on in oducing sel - egis e s
o e e yone and a g oup ha will be moni o ed us-
ing wea able sma wa ches.
►Mos heal hca e p o essionals can implemen he
in e en ion g oups.
►Some indi iduals may e use o pa icipa e in g oup
in e en ion o may wi hd aw om he s udy du ing
he 12- mon h ial pe iod.
►Di icul y o en i e g oup’s a endance o a session
held on one speci ic da e and ime.
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
2Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
(PHCs), he p e alence o dep ession anges om 9.6%
o 20.2%.6 7 Fu he mo e, dep ession gene a es g ea
disabili y and high economic and social cos s.8
The p e alence o dep ession in Spain is 13% o e
one’s li e ime and 4% pe yea .9 Indeed, como bidi y
wi h o he ch onic condi ions is high (64.9%–71.0%)
(diabe es, hype ension, ca dio ascula diseases and
cance , among o he s)10–12 as well as como bidi y wi h
o he psychia ic diseases such as anxie y diso de s is also
high (40%–66%).13
Despi e he nega i e impac o dep ession on people’s
li es and he exis ence o nume ous ea men in e en-
ions,14 hese in e en ions a e o en no app op ia ely
used in PHC se ices,6 mainly due o physician ime o
esou ce limi a ions.7 Thus, pha macological15 ea men
is usually ecommended, e en hough esea ch has shown
ha in subclinical, mild o mode a e dep ession, non-
pha macological in e en ions a e ecommended.15 16
Since op ions and ou comes o he ca e o indi iduals
su e ing om dep ession and hei access o ea men
emains limi ed,17 i is impo an o p omo e cos -
e ec i e ea men op ions. The onse and con inua ion
o dep ession has been linked o nume ous biological
and psychosocial ac o s, many o which a e ela ed o
dis inc li es yle aspec s.18–21 The e o e, many o he s a -
egies p omo ing a heal hie li es yle could ha e an ide-
p essan u ili y.20 22–24 In addi ion o mul imodal s udies,
o he s ha e ocused on one o he ollowing aspec s o
li es yle modi ica ion: daily physical ac i i y,25 adhe ence
o he Medi e anean die ,26 27 sleep hygiene p ac ices28 29
and ca e ul exposu e o sunligh .30 31
The p esen s udy will be amed a ound he heo y
o salu ogenesis,32 which es ablishes ha an indi idual’s
abili y o modi y ou li es yle is in luenced by psychoso-
cial gene alised esis ance esou ces, which consis o
pe sonal, in e pe sonal o con ex ual esou ces (money,
knowledge, expe ience, sel - es eem, heal hy habi s,
commi men , social suppo , cul u al capi al, in elligence,
adi ions and ision o li e) and he sense o cohe ence
(way o making sense o he wo ld, which is a majo ac o
in de e mining how well an indi idual manages s ess and
s ays heal hy).
Mo eo e , p e ious s udies show ha he use o acili a-
o s is qui e impo an (simplici y o guidelines, ailo ing
h ough mo i a ional in e iewing, p olonged and
in ense moni o ing h oughou he di e en s ages o
he diso de and he p o ision o adequa e eedback and
social suppo )23 o acili a e adhe ence o li es yle modi-
ica ion p og ammes (LMPs). Fo example, enhanced
mo i a ion can be achie ed h ough he use o in o ma-
ion and communica ion echnologies (ICTs) and wi h
he social suppo esul ing om in e en ion g oup
pa icipa ion.33 Pe sonal ac o s and acili a o s mus be
aken in o accoun in li es yle modi ica ion in e en ions,
since hey may de e mine he success o heal h p omo-
ion p og ammes.
The main objec i e o his p o ocol is o analyse he
clinical e ec i eness, cos - e ec i eness and cos u ili y o
an LMP and an LMP wi h ICTs as adjunc i e ea men
o dep ession in p ima y ca e pa ien s. The seconda y
objec i es a e o analyse he clinical e ec i eness in he
subg oup ha p esen s como bidi y and o analyse he
co ela ion be ween pe sonal ac o s on heal h beha iou
and li es yle pa e ns.
METHODS AND ANALYSIS
S udy design
Mul icen e p agma ic andomised con olled ial in
h ee pa allel g oups.
Se ing and s udy sample
We will ec ui pa ien s ha ing subclinical, mild o
mode a e dep ession (sco ing ≥10 and ≤30 poin s on he
Beck II Sel - Applied Dep ession In en o y (BDI- II))34
om PHCs o wo Spanish a eas (Za agoza and Mallo ca).
Inclusion c i e ia: indi iduals o e he age o 18, bo h
sexes, ha ing a du a ion o dep ession symp oms o a leas
2 mon hs, who unde s and w i en and spoken Spanish
and who ha e p o ided hei in o med consen (online
supplemen al ile 1). Exclusion c i e ia will be: su e ing
om ano he disease ha a ec s he b ain (o ganic b ain
pa hology o ha ing su e ed a auma ic b ain inju y o
any se e i y, demen ia); ha ing ano he psychia ic diag-
nosis o se ious psychia ic illness (subs ance dependence
o abuse, a his o y o schizoph enia o o he psycho ic
diso de s, ea ing diso de s) wi h he excep ion o anxious
pa hology o pe sonali y diso de s (collec ed h ough a
medical his o y and om he Mini- In e na ional Neu o-
psychia ic In e iew (MINI))35; p esence o a se ious o
uncon olled medical, in ec ious o degene a i e illness
ha may in e e e wi h he a ec i e symp oms; he p es-
ence o deli ium o hallucina ions, isk o suicide, p eg-
nancy o lac a ion; pa ien s who ha e pa icipa ed in
ano he clinical ial o e he pas 6 mon hs, who a e
cu en ly in psycho he apy o hose who ha e been p ac-
icing mind ulness, yoga, medi a ion o simila p ac ices
o e he pas 6 mon hs, engaging in o mal p ac ice a
leas once a week and he p esence o any medical,
psychological o social p oblem ha could se iously in e -
e e wi h he pa ien ’s pa icipa ion in he s udy.
Sample size
Scien i ic e idence sugges s ha a 17% educ ion in he
BDI- II34 is conside ed clinically ele an .36 In a p e ious
s udy conduc ed by ou eam wi h psychia ic ou pa ien s,
we ound ha he a e age BDI sco e a he beginning
o he s udy was 24.5 poin s (SD 9.8),22 so we conside
ha a educ ion o a leas 4.8 poin s would ha e clinical
signi icance and would bene i he pa ien . Accep ing an
α isk o 0.05 and a β isk o 0.20 in a bila e al con as ,
44 subjec s will be equi ed o each g oup. Wi h an
es ima ed wi hd awal a e o 20%, he sample size will
equi e app oxima ely 53 pa ien s in each g oup. The
o al sample equi ed is 159 subjec s. A o mula based
on he Snedeco ’s F dis ibu ion37 has been used (see
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
3
Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
online supplemen al ile 2). I is es ima ed ha app oxi-
ma ely 50% o hese pa ien s will p esen some physical o
men al como bidi y.12
Rec ui men
Gene al p ac i ione s (GPs) om he PHCs o Za a-
goza and Mallo ca will be in i ed o e e pa ien s who
a e suspec ed o su e ing om dep ession. Mos ep e-
sen a i e PHCs in he a ea will be in i ed, based on size,
u ban o u al a ea, and PHCs wi h a di e en sociode-
mog aphic p o ile will be selec ed. GPs will explain he
cha ac e is ics o he s udy o hei pa ien s and i hey
ag ee o pa icipa e, hey will be asked o p o ide a phone
numbe o be con ac ed by a ained esea ch assis an
(RA) du ing he nex week. The RA will call pa ien s and
es ablish an appoin men in hei PHC, in which he will
explain hem he s udy, p o ide hem he pa ien in o -
ma ion shee and ge he in o med consen signed. To
ensu e ha hey ul il he inclusion c i e ia, he RA will
adminis a e he BDI- II34 and he MINI.35 I pa icipan s
mee he c i e ia, he RA will adminis e he baseline
ques ionnai es a he same appoin men . Rec ui men
and baseline assessmen s will be ca ied ou un il he inal
sample size has been achie ed.
Randomisa ion, alloca ion and masking o s udy g oups
Once baseline da a a e collec ed, he pa icipan s will be
andomised. An independen s a is ician will pe o m he
indi idual andomisa ion using a compu e - gene a ed
andom numbe sequence. The andomisa ion will be
ca ied ou using a lis o pa ien s om Za agoza and
Mallo ca ( igu e 1). Gi en he na u e o he in e en-
ions, pa icipan s will no be blinded o hei alloca ion.
An RA will call hem o explain hei assigned in e en-
ion and whe e hey should go and when. The RA will
eques ha pa icipan s no o in o m o he esea che s
o hei alloca ion.
Da a collec ion and moni o ing
One RA will collec he da a and ano he will pe o m
en y and coding o he iden i ied da a. All RA managing
he da a will be blinded o pa icipan alloca ion, as well
as he RA conduc ing he ou come assessmen s and
da a analysis. All in o ma ion collec ed will be ea ed in
acco dance wi h he p o isions o cu en legisla ion on
pe sonal da a p o ec ion.
The s udy will no ha e a o mal da a moni o ing
commi ee since ad e se in e en ion e en s ha e no
been epo ed. Any se ious unexpec ed ad e se e en s
o ou comes will be discussed by he ial managemen
commi ee (iden ical o he au ho s o his p o ocol).
The e a e no plans o discon inue o modi y in e en-
ions, o o imp o e adhe ence o p omo e pa icipan
e en ion. The ial managemen commi ee will moni o
ec ui men , ea men and a i ion a es and any
conce ns ela ed o he s udy. Reasons o d opping ou
will be also egis e ed. Concomi an ca e is pe mi ed and
egis e ed as long as i is no one o he exclusion c i e ia.
G oup- speci ic p ocesses will be aken in o accoun and
will be e alua ed and in o med, in acco dance wi h
ecommenda ions o he ‘mechanisms o ac ion in g oup-
based in e en ions’ (MAGI) amewo k.38
In e en ion de elopmen and e alua ion
Pa ien s alloca ed in he i s a m (con ol g oup) will
ollow he usual ea men p o ided by hei GP ( ea -
men as usual (TAU)).
Pa ien s alloca ed in he second a m ( i s in e en ion
g oup) will ollow he TAU and he LMP. This p og amme
will consis o six weekly g oup sessions (las ing 90 min
each) led by an expe ienced psychologis and comple-
men ed by Powe Poin p esen a ions.
Pa ien s alloca ed in he hi d a m (second in e en ion
g oup) will ollow TAU and LMP and will be moni o ed
using a wea able sma w is wa ch ha will ack hei
daily sleep pa e ns and physical ac i i y (LMP+ICTs).
The g oup sessions will consis o he ollowing con en :
1. P esen a ion o he p ojec and psychoeduca ion on
dep ession: p esen a ion o he p ojec and a e iew
o he s udy objec i es. De ini ion, symp oms, causes,
consequences o dep ession and, also, how li es yles
and social en i onmen changes in luence he symp-
oma ology o dep ession.
2. Beha iou ac i a ion: a psychologis will p o ide in o -
ma ion on he impo ance o es ablishing, main aining
Figu e 1 Flowcha o he s udy: andomisa ion, sampling
and moni o ing o pa ien s. GP, gene al p ac i ione ; ICTs,
in o ma ion and communica ion echnologies; ITT, in en ion
o ea ; LMP, li es yle modi ica ion p og amme; MI, mul iple
impu a ion; TAU, ea men as usual.
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
4Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
and moni o ing ac i i ies. Fo he LMP+ICTs g oup,
hey will also lea n how o use he sma w is wa ch,
ensu ing all pa icipan s a e able o use i .
3. Sleep hygiene habi s and ca e ul exposu e o sunligh :
ecommenda ions on heal hy sleep habi s, ac o s in-
luencing sleep quali y and possible solu ions. The
bene i s o ca e ul exposu e o sunligh and ecom-
menda ions o when o do so and o how long. Re-
sponding o ques ions ega ding he p e ious session.
4. Physical ac i i y: he bene i s o engaging in egula
physical ac i i y. Pe sonalised ecommenda ions abou
wha physical exe cise may be p ac iced, how and
when o do so. Responding o ques ions ega ding he
p e ious session.
5. Adhe ence o he Medi e anean die : explana ions
abou he Medi e anean die , ood g oups and hei
cha ac e is ics, as well as he mos bene icial oods o
physical and men al heal h, how o cook i and ood-
ela ed habi s. Responding o ques ions ega ding he
p e ious session.
6. Summa y o p e ious sessions wi h p ac ical inal sug-
ges ions: pe sonalised expe iences and doub s o he
pa icipan s h oughou he cou se. Recommenda ions
o daily heal hy li es yle p ac ices o he u u e and
a ewell.
A he end o each session, he pa icipan s will ecei e
a pape wi h sel - egis a ion ables (online supplemen al
ile 3). They will comple e he ables wi h he in o ma ion
on hei daily ou ines ega ding he modi ica ion o li e-
s yles on which hey ha e been ins uc ed. They will be
asked abou when hey wake up and when hey go o bed,
he du a ion o hei sleep, he ime spen exposed o
sunligh , he die pa e n, he physical ac i i y and spo s
p ac iced, he social suppo and he subjec i e pe cep-
ion o sa is ac ion a e hese ac i i ies. A quali a i e
s udy associa ed wi h his s udy will be included o analyse
he pa icipan s' di icul ies in ollowing he in e en ion.
Ou comes and measu es
We will collec pa ien da a using he ques ionnai es
adminis e ed in baseline, immedia ely a e he in e en-
ion (in a pe iod o 2–7 days a e he las in e en ion
session) and a 6- mon h and 12- mon h ollow- up a e he
las in e en ion session (wi h a ma gin o ±2 weeks) (see
able 1). A blinded RA will call each pa ien o he h ee
a ms and se up an appoin men in hei PHC o ques-
ionnai e adminis a ion. S udy ou comes and measu es
a e summa ised in able 1.
Sociodemog aphic da a
We will collec in o ma ion on gende , age, ma i al s a us,
educa ion, occupa ion and economical le el. These da a
will be collec ed h ough an ad hoc ques ionnai e.
Table 1 S udy a iables
Ins umen Assessmen a ea Measu es
BDI- II34 39 Se e i y o dep ession Baseline and ollow- up sessions*
MINI35 Psychia ic diagnosis Baseline
Gende , age, ma i al s a us, educa ion, occupa ion,
economical le el
Sociodemog aphic Baseline and ollow- up sessions*
Glucose concen a ion (mg/dL), glyca ed haemoglobin
(%), c ea inine, a e ial p essu e (mm Hg) and choles e ol
(mg/dL)
Como bidi y wi h ch onic diseases Baseline and 6- mon h and
12- mon h ollow- up
EQ- 5D40 42 Heal h- ela ed quali y o li e Baseline and ollow- up sessions*
MOS- SS46 47 Social suppo Baseline and ollow- up sessions*
CSRI48 49 Heal h and social se ices use Baseline and ollow- up sessions*
IPAQ- SF50 51 Physical ac i i y Baseline and ollow- up sessions*
MEDAS53 54 Adhe ence o he Medi e anean die Baseline and ollow- up sessions*
PSQI55 56 Quali y and pa e ns o sleep Baseline and ollow- up sessions*
Sel - E icacy Scale57 62 Sel - e icacy Baseline and ollow- up sessions*
PAM58 63 Pa ien ac i a ion in hei own heal h Baseline and ollow- up sessions*
SOC-1359 64 Sense o cohe ence Baseline and ollow- up sessions*
HLS- EUQ1660 65 Heal h li e acy Baseline and ollow- up sessions*
IPS61 66 P oc as ina ion Baseline and ollow- up sessions*
*Follow- up sessions: pos in e en ion (in a pe iod o 2–7 days a e he las session o he in e en ion) and 6- mon h and 12- mon h
ollow- up (6 and 12 mon hs a e he las session o he in e en ion (±2 weeks)).
BDI- II, Beck II Sel - Applied Dep ession In en o y; CSRI, Clien Se ice Receip In en o y; EQ- 5D, Eu opean Quali y o Li e-5 Dimensions
Ques ionnai e; HLS- EUQ16, Heal h Li e acy Eu ope Ques ionnai e; IPAQ- SF, In e na ional Physical Ac i i y Ques ionnai e- Sho Fo m;
IPS, I a ional P oc as ina ion Scale; MEDAS, 14- i em Medi e anean Die Adhe ence Sc eene ; MINI, Mini- In e na ional Neu opsychia ic
In e iew; MOS- SS, Medical Ou comes S udy Social Suppo Su ey; PAM, Pa ien Ac i a ion Measu e Ques ionnai e; PSQI, Pi sbu gh
Sleep Quali y Index; SOC-13, Sense o Cohe ence Ques ionnai e.
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
5
Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
P ima y ou come
Se e i y o dep ession
The p ima y ou come will be measu ed using he BDI- II.34
This is a sel - epo in en o y o measu ing he se e i y
o dep ession, consis ing o 21 mul iple- choice ques ions
wi h each answe being sco ed on a scale anging om 0
o 3. I was ansla ed and alida ed in o Spanish wi h a
eliabili y o 0.89.39 The s anda dised cu o s a e: 0–13:
minimal dep ession; 14–19: mild dep ession; 20–28:
mode a e dep ession and 29–63: se e e dep ession.
Seconda y ou comes
Heal h- ela ed quali y o li e
Heal h- ela ed quali y o li e will be measu ed using he
Eu opean Quali y o Li e-5 Dimensions Ques ionnai e
(EQ- 5D).40 41 EQ- 5D sco es will be used o calcula e
he quali y- adjus ed li e yea (QALY) du ing he moni-
o ing pe iod by adjus ing he leng h o ime a ec ed
by he heal h esul by he u ili y alue. I con ains i e
heal h dimensions (mobili y, sel - ca e, usual ac i i ies,
pain/discom o and anxie y/dep ession) and each o
hese has h ee le els (no p oblems, sligh p oblems o
mode a e and se e e p oblems). The EQ eco ds he
pa ien ’s sel - a ed heal h on a e ical Visual Analogue
Scale (VAS) o 20 cm, whe e he endpoin s a e labelled
‘The bes heal h you can imagine’ and ‘The wo s heal h
you can imagine’. The VAS can be used as a quan i a i e
measu e o heal h ou come ha e lec he pa ien ’s own
judgemen . Pa ien s ma k he poin on he e ical line
ha bes e lec s hei assessmen o hei cu en global
heal h s a us.42 C onbach’s alpha coe icien has been
calcula ed in esea ch wi h disease- speci ic popula ions.
We highligh he s udy o Seoane e al43 in which he
o e all alpha alue was 0.788. Being he only s udy wi h a
gene al popula ion, i p o ides an o e all mean es ima e
o he minimum impo an di e ence o he EQ- 5D,
which is 0.074.44
Como bidi y wi h ch onic diseases
Como bidi y wi h ch onic diseases will be de e mined
acco ding o he In e na ional Classi ica ion o Diseases,
Ten h Re ision45: diabe es (glucose concen a ion
(mg/dL), glyca ed haemoglobin (%), c ea inine, a e-
ial hype ension and diseases o lipid me abolism. In
pa ien s wi h ch onic hea disease, coagula ion a iables
will be added. They will be collec ed om he las blood
es o con ol measu emen s o he clinical his o y, aken
by hei GP o nu se (assuming hey we e aken o e he
pas 3 mon hs). O he wise, hei GP will be asked o a
blood con ol es . I is es ima ed ha app oxima ely 50%
o hese pa ien s will p esen some como bidi y.12 An h o-
pome ic measu es will also be collec ed (weigh , size and
pe ime e o he wais ).
Social suppo
I will be measu ed by he Medical Ou comes S udy Social
Suppo Su ey (MOS- SS).46 I is a sel - epo ins umen
consis ing o ou subscales (emo ional/in o ma ional,
angible, a ec iona e and posi i e social in e ac ion) and
an o e all unc ional social suppo index. I has a good
eliabili y (C onbach’s alpha ≥0.91) and is qui e s able
o e ime. I has 19 i ems, a 5- poin Like Scale. Highe
sco es indica e mo e suppo . We will use he Spanish ali-
da ed e sion.47
Use o heal h and social se ices
I will be measu ed using he Clien Se ice Receip In en-
o y.48 These da a may be used o a wide ange o appli-
ca ions, including es ima es o he cos s o se ice eceip .
To collec in o ma ion on he en i e ange o se ices
and suppo s used by s udy pa icipan s. I e ospec i ely
collec s da a on he use o se ices o e he pas 6 mon hs
(eg, a es o use o indi idual se ices, mean in ensi y o
se ice use, a es o accommoda ion use o e ime). We
will use he alida ed Spanish e sion.49
Assessmen o li es yle
Physical ac i i y
Physical ac i i y will be measu ed using he In e na ional
Physical Ac i i y Ques ionnai e- Sho Fo m (IPAQ- SF).50
I assesses he le els o habi ual physical ac i i y o e he
las 7 days. I has se en i ems and eco ds he ac i i y
o ou in ensi y le els: igo ous- in ensi y ac i i y and
mode a e- in ensi y ac i i y (walking and si ing). We will
use he alida ed Spanish e sion.51 IPAQ- SF has accep -
able alidi y o he measu emen o o al and igo ous
physical ac i i y and poo alidi y o mode a e ac i i y
and good eliabili y.52
Adhe ence o he Medi e anean die
Adhe ence o he Medi e anean die will be measu ed
using he 14- i em Medi e anean Die Adhe ence
Sc eene (MEDAS), de eloped wi hin he p e en ion
wi h Medi e ean die (PREDIMED) s udy g oup.53 I
includes i ems on ood consump ion and in ake habi s:
he use o oli e oil as he main sou ce o cooking a , p e -
e ence o whi e mea o e ed mea , se ings o ege a-
bles, po ions o ui , ed mea o sausages, se ings o
animal a , suga - swee ened be e ages, ed wine, legumes,
ish, comme cial pas ies and d essing ood wi h a adi-
ional sauce made o oma oes, ga lic, onion o leeks
sau éed in oli e oil. The o al sco e anges om 0 o 14,
wi h a highe sco e indica ing a be e acco dance wi h
he Medi e anean die .54
Quali y and pa e ns o sleep
Quali y and pa e ns o sleep will be measu ed using he
Pi sbu gh Sleep Quali y Index (PSQI).55 I di e en i-
a es be ween ‘poo ’ and ‘good’ sleep by measu ing se en
domains: subjec i e sleep quali y, sleep la ency, sleep
du a ion, habi ual sleep e iciency, sleep dis u bances,
use o sleep medica ion and day ime dys unc ion o e he
pas mon h. I consis s o 19 sel - applied ques ions and
i e ques ions ha eques he e alua ion o he pa ien ’s
bedma e o oomma e ( hese a e no sco ed). Answe s
ange om 0 (no di icul y) o 3 (se e e di icul y). The
o e all sco e anges om 0 o 21 poin s. In i s Spanish
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om

6Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
e sion, he C onbach’s alpha coe icien is 0.81, sensi-
i i y is 88.63% and speci ici y is 74.99%. We will use he
alida ed Spanish e sion.56
Pe sonal ac o s on heal h beha io
We will assess: (1) sel - e icacy57; (2) ac i a ion58; (3)
sense o cohe ence59; (4) heal h li e acy60 and (5)
p oc as ina ion.61
Sel -e icacy
Sel - e icacy will be measu ed using he Sel - E icacy
Scale.57 To measu e Gene al Sel - E icacy Subscale (17
i ems including indi iduals' belie s in hei abili y o
pe o m well in a a ie y o si ua ions) and Social Sel -
E icacy Subscale (six i ems). I con ains 23 i ems ha a e
a ed on a 14- poin scale ( anging om s ongly ag ee o
s ongly disag ee). Highe sco es indica e highe le els o
sel - e icacy. I has a C onbach coe icien alpha o 0.86
o Gene al Sel - E icacy Subscale and 0.71 o he Social
Sel - E icacy Subscale. The unpublished Spanish e sion
was ansla ed by Godoy in 1990.62
Pa ien ac i a ion in hei own heal h
Pa ien ac i a ion in hei own heal h will be measu ed
using he Pa ien Ac i a ion Measu e (PAM) Ques ion-
nai e wi h ega d o he managemen o hei heal h.58
I e alua es he pa ien ’s pe cei ed knowledge, skills and
con idence o engage in sel - managemen ac i i ies. I has
13 i ems wi h a Like Scale om 1 (s ongly disag ee)
o 4 (s ongly ag ee). The esul ing sco e (be ween 0
and 100) places he indi idual a one o ou le els o
ac i a ion, each o which e eals insigh in o a ange o
heal h- ela ed cha ac e is ics, including beha iou s and
ou comes. Highe sco es indica e highe le els o ac i a-
ion.58 This scale is only alida ed in Spanish o ch onic
pa ien s. I had an i em sepa a ion index o he pa ame-
e s o 6.64 and a eliabili y o 0.98.63
Sense o cohe ence
Sense o cohe ence will be measu ed using he Sense o
Cohe ence (SOC-13) Ques ionnai e by An ono sky.59 I
alues he pe sonal disposi ion owa ds he assessmen
o i al expe iences. I measu es he sense o cohe ence,
comp ehensibili y, manageabili y and meaning ulness.
I has 13 i ems sco ing be ween 13 and 91 poin s. I has
consis ency a es be ween 0.84 and 0.93. Highe sco es
(a e e e sal o he in e ed i ems) indica e a highe
sense o cohe ence. We will use he alida ed Spanish
e sion.64
Heal h li e acy
Heal h li e acy will be measu ed using he Heal h Li e acy
Eu ope Ques ionnai e (HLS- EUQ16).60 I can indica e
ha he p obabili y o unc ional li e acy in limi ed heal h
is high, a possibili y o unc ional li e acy in limi ed
heal h, and unc ional heal h li e acy in adequa e heal h.
I con ains 16 i ems. Highe sco es indica e be e heal h
li e acy. I p esen s a high consis ency (C onbach’s alpha
o 0.982) in he Spanish alida ion.65
P oc as ina ion
P oc as ina ion will be measu ed using he I a ional
P oc as ina ion Scale (IPS).66 To measu e gene al p oc as-
ina ion (dys unc ional delay). I has nine i ems, a ed on
a 5- poin Like Scale, wi h highe sco es (a e e e sal o
he h ee p oc as ina ion- inconsis en i ems) indica ing
a highe le el o p oc as ina ion. I s C onbach’s alpha
alue is 0.90. We will use he alida ed Spanish e sion.61
Da a analysis plan
Analysis o he ou comes a baseline
Fi s , desc ip i e analyses o all he a iables (p opo -
ions o quali a i e a iables, means and SD o quan-
i a i e a iables) will be pe o med. Then, co ela ion
analysis will be ca ied ou be ween he ques ionnai es
ha e alua e pe sonal ac o s on heal h beha iou (Sel -
E icacy Scale, PAM, SOC-13, HLS- EUQ16 and IPS),
social suppo (MOS- SS) and dep ession (BDI- II). We will
also analyse he co ela ion be ween pe sonal ac o s on
heal h beha iou and he ques ionnai es assessing li e-
s yle pa e ns (IPAQ- SF, MEDAS and PSQI). Finally, we
will analyse he ela ion o li es yle pa e ns and social
suppo wi h dep ession. In e en ial s a is ical analysis
will be ca ied ou using he χ2 es o quali a i e a i-
ables, and S uden ’s - es o one- wayanalysis o a iance
(ANOVA) es o assess he po en ial ela ionship be ween
quali a i e and quan i a i e a iables.
Da a collec ion and s a is ical analysis will be pe o med
using Excel so wa e, SPSS so wa e (V.25.0)67 and he R
s a is ical so wa e en i onmen (V.3.6.2).68
Clinical e ec i eness analysis
The epo o he esul s will ollow a p especi ied plan,
based on he Consolida ed S anda ds o Repo ing T ials
guidelines69 in o de o compa e he h ee g oups using
an in en ion- o- ea analysis and mul iple impu a ion
(MI) echnique o handling missing da a. Ini ially, a
desc ip i e compa ison (p opo ions, means o medians)
will be ca ied ou be ween g oups o p ognos ic a i-
ables in o de o es ablish hei baseline compa abili y
a e andomisa ion. To analyse he clinical e ec i eness,
a epea ed- measu e linea eg ession will be conduc ed,
including all e alua ions o e ime. Fo his pu pose,
he main a iable, BDI- II sco e, will be used as a con in-
uous a iable. The models will include adjus men s o
he baseline alue o he BDI- II and o any o he a i-
able ha would ha e shown di e ences in he baseline
measu emen . Possible g oup pe ime in e ac ions will
be examined using linea eg ession. Simila analyses will
be ca ied ou using he seconda y ou comes (pe sonal
ac o s on heal h beha iou and assessmen o li es yle).
To coun e ac he p oblem o mul iple compa isons, we
will use Bon e oni co ec ion.
Compa isons will also be made be ween he LMP
and LMP+ICTs g oups ega ding adhe ence o li es yle
modi ica ion equi emen s. Adhe ence will be consid-
e ed as a good o bene icial sco e on he ques ionnai es
assessing li es yle pa e ns (IPAQ- SF, MEDAS and PSQI).
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
7
Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
In addi ion, we will compa e he LMP and combined
LMP+ICTs g oups, assuming ha hey a e compa able o
each o he and he wo g oups ha e signi ican esul s.
A bina y a iable ega ding como bidi y will be c ea ed
(como bidi y yes/no). We will de e mine i he e ec-
i eness o he in e en ion di e s in he subg oup
p esen ing como bidi y and i he pa hology imp o es.
S a is ical analyses will be selec ed based on subsample
size (pa ame ic o non- pa ame ic es s).
As o he imepoin in which we adminis a e he
ollow- up ques ionnai es, we will conside he i s
ollow- up assessmen (in a pe iod o 2–7 days a e he las
session o he in e en ion) as mo e ele an . We expec
o ind an immedia e e ec in he LMP and LMP+ICTs
g oups a e a ending g oup in e en ion, due o he
po en ial social suppo ecei ed. In he 6- mon h and
12- mon h ollow- up, we expec a bene icial change in he
ques ionnai es assessing li es yle, e lec ing a long- las ing
e ec .
Cos -e ec i eness and cos -u ili y analysis
The e ec i eness o he in e en ions will be es ima ed
using he di e ence be ween he BDI- II baseline sco e
and he sco e a he 6- mon h and 12- mon h ollow- ups,
and u ili y will be es ima ed using QALYs a he 6- mon h
and 12- mon h ollow- ups. QALYs will be calcula ed based
on hese sco es using he Spanish EQ- 5D a i s.70 Along
wi h he EQ- 5D u ili y sco es, sco es eco ded on he EQ
VAS will also be used as an ou come o he analysis.
Cos - e ec i eness will be explo ed h ough he calcu-
la ion o inc emen al cos - e ec i eness a ios (ICERs)
o he ac i e in e en ion g oups (LMP and LMP+ICTs)
using he TAU g oup as he con ol. ICER is de ined as
he a io be ween inc emen al cos s and inc emen al
e ec i eness. In his way, cos u ili y will be explo ed
by calcula ing inc emen al cos - u ili y a ios, which a e
de ined as he a io be ween inc emen al cos s and inc e-
men al u ili ies measu ed on QALYs. QALYs gained in
each e alua ion a e app oxima ed using he a ea unde
he cu e echnique.71
To al cos s will be calcula ed by adding di ec and indi-
ec cos s. Di ec cos s will be calcula ed by adding he
cos s de i ed om he medica ion and he use o heal h
se ices and clinical es s. The medica ion cos s will be
calcula ed by de e mining he p ice pe millig am du ing
he s udy pe iod acco ding o he ade- mecum o he las
yea o s udy, including alue- added ax. The o al cos o
d ug ea men will be calcula ed by mul iplying he p ice
pe millig am by he daily dose in millig ams and he
numbe o days he ea men is ecei ed. Cos s de i ed
om he use o heal h se ices will be calcula ed consid-
e ing he da a om he Oblikue da abase.72 Indi ec cos s
will be calcula ed based on he sick lea e days and mul i-
plying hem by he Spanish minimum daily wage du ing
he s udy pe iod, 2019–2020.
We assume ha da a will be missing a andom. Only
pa ien s wi h bo h cos and ele an ou come da a a he
6- mon h and 12- mon h ollow- ups will be included in he
cos - e ec i eness and cos - u ili y analyses. No wi hs anding
his, sensi i i y analysis impu ing missing 6- mon h and
12- mon h da a will es he obus ness o cos - e ec i eness
and cos - u ili y esul s. The impu a ions will be pe o med
using he ‘mice’ package,73 eely a ailable in he Comp e-
hensi e R A chi e Ne wo k (CRAN- R).68
DISCUSSION
Dep ession is a signi ican cause o mo bidi y ha ing low
de ec ion and ea men a es in p ima y ca e.74 75 Only 9%
o all dep essed p ima y ca e pa ien s ecei e adequa e ea -
men , and only 6% achie e emission, making dep ession an
impo an managemen issue in p ima y ca e.76 An e ec i e
ea men o dep ession ha can be implemen ed in PHCs
is b ie psycho he apy (six o eigh sessions p og ammes),
which ha e he ad an age o being pe o med by ei he
men al heal h p o essionals o ained non- men al heal h
p o ide s.77 In his case, he p omo ion o heal hy li es yles
will be used o add ess dep essi e symp oms, as i has shown
e icacy in a numbe o s udies.20–31 To ensu e ea men
adhe ence, acili a o s should be used, such as he use o ICTs
and he g oup o ma . They p o ide moni o ing and social
suppo , espec i ely.33 O ganising g oup he apies in PHCs
gene a es a ange o o ganisa ional bene i s, in ela ion o
e icien use o acili ies, high he apis - o- pa ien a ios and
po en ial educ ions o ea men wai imes.78 Mo eo e ,
pa icipan s a e jus as likely o engage in g oup ea men
as indi idual wo k and he bene i s a e also main ained o e
ime.79
The s eng hs o his s udy include he design and he
wide ange o ou come measu es. I will p o ide a weal h o
in o ma ion on he in e play be ween dep ession, pe sonal
ac o s on heal h beha iou and li es yles. S udy limi a ions
include he possible a i ion o pa icipan s due o session
scheduling o pa icipan e usal o pa icipa e in a g oup
in e en ion o do he comple e ollow- ups.80 Howe e , he
possible easons o a i ion and o he issues will be egis-
e ed ega ding MAGI amewo k.38
The e o e, he c ea ion o a six- session g oup p og amme
add essing li es yle modi ica ions (plus es ing he moni-
o ing wi h ICTs by adding a sma wa ch o one o he in e -
en ion g oup) appea s o be a good choice o dep ession
ea men . The long- e m aim o his s udy is o es ablish
in e en ion o pa ien s wi h dep ession, making i acces-
sible in hei PHCs, e ec i e and cos - e ec i e.
Execu ion da es
Ini ial ec ui men o pa ien s: Ap il 2020.
Finalisa ion o pa ien ec ui men : May 2020.
Finalisa ion o pa ien moni o ing pe iod: June 2021.
Publica ion o esul s: July 2021.
Pa ial pa ien and public in ol emen (PPI)
PPI ep esen a i es wo ked wi h us o e ine he esea ch
ques ion; howe e , i was di icul o in ol e pa ien s in o he
a eas o he s udy design due o da a p o ec ion es ic ions
and he e y echnical me hods equi ed o do a da a linkage
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
8Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
analysis. PPI ep esen a i es will w i e a plain language
summa y and design a lea le o dissemina ion o hei pee s
and dis ibu ing o pa ien g oups.
ETHICS APPROVAL
E hics app o al was g an ed by he Clinical Resea ch E hics
Commi ee o A agón (PI18/286) and he Resea ch E hics
Commi ee o he Balea ic Islands (IB3950/19 PI). The s udy
has been de eloped in acco dance wi h he Decla a ion o
Helsinki. All o he subjec s will sign an in o med consen
o m, hei da a will be anonymised and will only be used
o he pu poses o he s udy. Pa icipan s and heal hca e
p o essionals will be in o med abou he esul s. Pa ien s o
he TAU g oup will be in i ed o pa icipa e in he LMP a he
end o he s udy. The e hics commi ee will be no i ied o any
p o ocol modi ica ions.
Au ho a ilia ions
1P ima y Heal h Ca e Resea ch G oup o A agón (GAIAP), Ins i u e o Heal h
Resea ch A agón (IIS A agón), Za agoza, Spain
2Depa men o Psychology, Uni e si y o he Balea ic Islands, Palma de Mallo ca,
Spain
3Depa men o Psychology and Sociology, Uni e si y o Za agoza, Za agoza, Spain
4S a is ic and psychome ic p ocedu es implemen ed in Heal h Sciences Resea ch
G oup, Balea ic Islands Heal h Resea ch Ins i u e (IdISBa), Palma de Mallo ca, Spain
5Depa men o Medicine, Psychia y and De ma ology, Uni e si y o Za agoza,
Za agoza, Spain
6Men al diso de s o high p e alence Resea ch G oup (TRAMAP), Balea ic Islands
Heal h Resea ch Ins i u e (IdISBa), Palma de Mallo ca, Spain
7Depa men o Medicine, Uni e si y o he Balea ic Islands, Palma de Mallo ca,
Spain
8Resea ch in P e en i e Ac i i ies and P omo ion and in Cance Illes Balea s
(GRAPP- CAIB), Balea ic Islands Heal h Resea ch Ins i u e (IdISBa), Palma de
Mallo ca, Spain
Acknowledgemen s The au ho s would like o hank he P ima y Ca e P e en ion
and Heal h P omo ion Ne wo k (RedIAPP- Heal h Ins i u e Ca los III, Spain), P ima y
Heal h Ca e Resea ch G oup o A agon (GAIAP- B21- 17R) o he Depa men o
Science, Uni e si y and Knowledge Socie y o he A agon (Spain) go e nmen and
FEDER Funds ‘Ano he way o make Eu ope’.
Con ibu o s BO- B, M- JS- R and MG- T designed and de eloped he s udy and had
he o iginal idea. RMB, M- JS- R, CN and BO- B coo dina ed he ieldwo k. AA- L and
CCV unde ook he ieldwo k. AA- L, BO- B, EG and SB w o e he i s d a o he
a icle. The es o he signing au ho s ha e ead he manusc ip c i ically, o e ing
con ibu ions and app o ing he inal e sion. BO- B a es s ha all lis ed au ho s
mee au ho ship c i e ia and ha no o he s mee ing he c i e ia ha e been omi ed.
Funding This wo k was suppo ed by Ca los III Heal h Ins i u e g an numbe
PI18/01336, FEDER Funds ‘Ano he way o make Eu ope’. The unde s ha e no
ole in s udy design, da a collec ion and analysis, decision o publish o manusc ip
p epa a ion. The unding body will conduc audi ial once a yea .
Compe ing in e es s None decla ed.
Pa ien consen o publica ion No equi ed.
Supplemen al ma e ial This con en has been supplied by he au ho (s). I has
no been e ed by BMJ Publishing G oup Limi ed (BMJ) and may no ha e been
pee - e iewed. Any opinions o ecommenda ions discussed a e solely hose
o he au ho (s) and a e no endo sed by BMJ. BMJ disclaims all liabili y and
esponsibili y a ising om any eliance placed on he con en . Whe e he con en
includes any ansla ed ma e ial, BMJ does no wa an he accu acy and eliabili y
o he ansla ions (including bu no limi ed o local egula ions, clinical guidelines,
e minology, d ug names and d ug dosages), and is no esponsible o any e o
and/o omissions a ising om ansla ion and adap a ion o o he wise.
Open access This is an open access a icle dis ibu ed in acco dance wi h he
C ea i e Commons A ibu ion Non Comme cial (CC BY- NC 4.0) license, which
pe mi s o he s o dis ibu e, emix, adap , build upon his wo k non- comme cially,
and license hei de i a i e wo ks on di e en e ms, p o ided he o iginal wo k is
p ope ly ci ed, app op ia e c edi is gi en, any changes made indica ed, and he use
is non- comme cial. See:h p:// c ea i ecommons. o g/ licenses/ by- nc/ 4. 0/.
ORCID iD
Alejand aAguila - La o e h p:// o cid. o g/ 0000- 0003- 2683- 7346
REFERENCES
1 Fe a i AJ, Cha lson FJ, No man RE, e al. Bu den o dep essi e
diso de s by coun y, sex, age, and yea : indings om he global
bu den o disease s udy 2010. PLoS Med 2013.
2 Gabilondo A, Rojas- Fa e as S, Vilagu G, e al. Epidemiology o
majo dep essi e episode in a sou he n Eu opean coun y: esul s
om he ESEMeD- Spain p ojec . J A ec Diso d 2010;120:76–85.
3 Depa men o In o ma ion E idence and Resea ch WHO. WHO
me hods and da a sou ces o global bu den o disease es ima es
2000-2015 [online]. Global Heal h Es ima es Technical Pape
WHO/HIS/IER/GHE/2017.1, 2017. A ailable: h ps://www. who. in /
heal hin o/ global_ bu den_ disease/ GlobalDALYme hods_ 2000_ 2015.
pd ? ua=1
4 Alonso J, Ange meye MC, Be ne S, e al. P e alence o
men al diso de s in Eu ope: esul s om he Eu opean s udy o
he epidemiology o men al diso de s (ESEMeD) p ojec . Ac a
Psychia ica Scandina ica, supplemen , 2004.
5 Kessle RC, B ome EJ. The epidemiology o dep ession ac oss
cul u es. Annu Re Public Heal h 2013;34:119–38.
6 Vindel AC, Salgue o JM, Wood CM, e al. La dep esión en a ención
p ima ia: p e alencia, diagnós ico Y a amien o. Papeles del
psicólogo 2012;33:2–11.
7 Codony M, Alonso J, Almansa J, e al. Men al heal h ca e use in he
Spanish gene al popula ions. Resul s o he ESEMeD- Spain s udy |
U ilización de Los se icios de salud men al en La población Gene al
española. Resul ados del es udio ESEMeD- España. Ac as españolas
Psiquia 2007;35:21–8.
8 Andlin- Sobocki P, Jönsson B, Wi chen HU, e al. Cos o diso de s
o he b ain in Eu ope. Eu J Neu ol 2005.
9 Alonso J, Ange meye MC, Be ne S, e al. Use o men al heal h
se ices in Eu ope: esul s om he Eu opean s udy o he
epidemiology o men al diso de s (ESEMeD) p ojec . Ac a Psychia
Scand Suppl 2004:47–54.
10 In:Cassano P, Fa a M. Dep ession and public heal h: an o e iew. J
Psychosom Res 2002;53:849–57.
11 O’Neil A, Jacka FN, Qui k SE, e al. A sha ed amewo k o he
common men al diso de s and non- communicable disease: key
conside a ions o disease p e en ion and con ol. BMC Psychia y
2015;15.
12 Ka on WJ. Clinical and heal h se ices ela ionships be ween majo
dep ession, dep essi e symp oms, and gene al medical illness. Biol
Psychia y 2003;54:216–26.
13 A agonès E, Piñol JL, Labad A, e al. P e alence and de e minan s
o dep essi e diso de s in p ima y ca e p ac ice in Spain. In J
Psychia y Med 2004;34:21–35.
14 Da idson JRT. Majo dep essi e diso de ea men guidelines in
Ame ica and Eu ope. J Clin Psychia y 2010;71:e04.
15 Cuijpe s P, an S a en A, an Schaik A, e al. Psychological
ea men o dep ession in p ima y ca e: a me a- analysis. B i ish
Jou nal o Gene al P ac ice 2009;59:e51–60.
16 Na ional Collabo a ing Cen e o Men al Heal h. Dep ession: he
NICE guideline on he ea men and managemen o dep ession in
adul s. Economis 2010.
17 Wi chen HU, Jacobi F, Rehm J, e al. The size and bu den o men al
diso de s and o he diso de s o he b ain in Eu ope 2010. Eu opean
Neu opsychopha macology 2011;21:655–79.
18 Hidaka BH. Dep ession as a disease o mode ni y: explana ions o
inc easing p e alence. J A ec Diso d 2012;140:205–14.
19 Kup e DJ, F ank E, Phillips ML. Majo dep essi e diso de : new
clinical, neu obiological, and ea men pe spec i es. Lance
2012;379:1045–55.
20 Lop es i AL, Hood SD, D ummond PD. A e iew o li es yle ac o s
ha con ibu e o impo an pa hways associa ed wi h majo
dep ession: die , sleep and exe cise. J A ec Diso d 2013;148:12–27.
21 Toobe DJ, Glasgow RE, S ycke LA, e al. Long- e m e ec s o
he Medi e anean li es yle p og am: a andomized clinical ial o
pos menopausal women wi h ype 2 diabe es. In J Beha Nu Phys
Ac 2007;4:1.
22 Ga cía- To o M, Iba a O, Gili M, e al. Fou hygienic- die a y
ecommenda ions as add- on ea men in dep ession a andomized-
con olled ial. J A ec Diso d [In e ne ] 2012;140:200–3.
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om
9
Aguila - La o eA, e al. BMJ Open 2020;10:e038457. doi:10.1136/bmjopen-2020-038457
Open access
23 Oli an- Blázquez B, Mon e o- Ma in J, Ga cía- To o M, e al.
Facili a o s and ba ie s o modi ying die a y and hygiene beha iou s
as adju an ea men in pa ien s wi h dep ession in p ima y ca e: a
quali a i e s udy. BMC Psychia y 2018;18:1–12.
24 Fo sy h A, Deane FP, Williams P. A li es yle in e en ion o p ima y
ca e pa ien s wi h dep ession and anxie y: A andomised con olled
ial. Psychia y Res 2015:1–8.
25 Ha ey SB, O e land S, Ha ch SL, e al. Exe cise and he p e en ion
o dep ession: esul s o he HUNT coho s udy. Am J Psychia y
2018.
26 Roca M, Kohls E, Gili M, e al. P e en ion o dep ession h ough
nu i ional s a egies in high- isk pe sons: a ionale and design o he
MooDFOOD p e en ion ial. BMC Psychia y 2016;16.
27 Sánchez- Villegas A, Hen íquez P, Bes- Ras ollo M, e al.
Medi e anean die and dep ession. Public Heal h Nu
2006;9:1104–9.
28 Mee lo P, Ha ekes R, S eige A. Ch onically es ic ed o dis up ed
sleep as a causal ac o in he de elopmen o dep ession. Cu Top
Beha Neu osci 2015.
29 Coughlin JW, Smi h MT. Sleep, obesi y, and weigh loss in adul s: is
he e a a ionale o p o iding sleep in e en ions in he ea men o
obesi y? In Re Psychia y 2014.
30 Tuunainen A, K ipke DF, Endo T, e al. Ligh he apy o non- seasonal
dep ession. Coch ane Da abase Sys Re 2004;64:CD004050.
31 Golden RN, Gaynes BN, Eks om RD, e al. The e icacy o
ligh he apy in he ea men o mood diso de s: a e iew and
me a- analysis o he e idence. Ame ican Jou nal o Psychia y
2005;162:656–62.
32 An ono sky A. The salu ogenic model as a heo y o guide heal h
p omo ion. Heal h P omo In 1996;11:11–18.
33 NICE. Beha iou change: indi idual app oaches [online], 2014.
A ailable: www. nice. o g. uk/ guidance/ ph49
34 Beck A, S ee R, Ball R, e al. Compa ison o beck dep ession 1
in psychia ic in en o ies -1A and - ou pa ien s. J Pe s Assess
1996;67:588–97.
35 Fe ando L, Bobes J, MINI GJ. Mini in e na ional neu opsychia ic
in e iew. Ve sión en Español 5.0.0 DSM- IV. Ins umen os De ección
y O ien ación Diagnós ica 2000.
36 Bu on KS, Kounali D, Thomas L, e al. Minimal clinically impo an
di e ence on he Beck Dep ession In en o y- II acco ding o he
pa ien ’s pe spec i e. Psychol Med 2015.
37 Makuch R, Simon R. Sample size equi emen s o e alua ing a
conse a i e he apy. Cance T ea Rep 1978.
38 Bo ek AJ, Ab aham C, G ea es CJ, e al. Iden i ying change
p ocesses in g oup- based heal h beha iou - change in e en ions:
de elopmen o he mechanisms o ac ion in g oup- based
in e en ions (MAGI) amewo k. Heal h Psychol Re 2019;13:227–47.
39 Sanz J, Ga cía- Ve a MP, Espinosa R, e al. Spanish adap a ion
o he Beck dep ession In en o y- II (BDI- II): 3. psychome ic
ea u es in pa iens wi h psychological diso de s. Clínica y
Salud 2005;16:121–42 h p://www. edalyc. o g/ esumen. oa? id=
180616104001
40 B ooks R, De Cha o F. Eu oQol: he cu en s a e o play. heal h
policy. New Yo k, 1996.
41 The Eu oQol G oup. Eu oQol - a new acili y o he measu emen o
heal h- ela ed quali y o li e. Heal h Policy 1990;16:199–208.
42 Badia X, Rose M, Mon se a S, e al. [The Spanish e sion o
Eu oQol: a desc ip ion and i s applica ions. Eu opean quali y o li e
scale]. Med Clin 1999.
43 Seoane B, de la Iglesia F, Nicolás R, e al. Análisis ac o ial de la
calidad de ida elacionada Con La salud de pacien es que ing esan
en Una unidad de co a es ancia médica. Re . méd. Chile 2009;137.
44 Wal e s SJ, B azie JE. Compa ison o he minimally impo an
di e ence o wo heal h s a e u ili y measu es: EQ- 5D and SF- 6D.
Qual Li e Res 2005;14:1523–32.
45 WHO. In e na ional classi ica ion o diseases (ICD-10). Fam P ac
Manag 2010.
46 She bou ne CD, S ewa AL. The mos social suppo su ey. Soc Sci
Med 1991;32:705–14.
47 de la Re illa- Ahumada L, Luna del Cas illo J. Bailón Muñoz E MMI.
[Valida ion o a ques ionnai e o measu ed social suppo in P ima y
Ca e]. Med Fam 2005.
48 Knapp M. Economic e alua ion o men al heal h ca e. In:
Con empo a y Psychia y, 2001.
49 Vazquez- Ba que o JL, Gai e L, Cues a MJ, e al. Spanish e sion o
he CSRI: A men al heal h cos e alua ion in e iew. [Spanish e sion
o he CSRI: A men al heal h cos e alua ion in e iew]. A chi os de
Neu obiología 1997.
50 Kim Y, Pa k I, Kang M. Con e gen alidi y o he In e na ional
physical ac i i y ques ionnai e (IPAQ): me a- analysis. Public Heal h
Nu 2013;16:440–52.
51 Roman- Viñas B, Se a- Majem L, Hags öme M, e al. In e na ional
physical ac i i y ques ionnai e: eliabili y and alidi y in a Spanish
popula ion. Eu J Spo Sci 2010;10:297–304.
52 Ku ze N, Rangul V, Hus ed B- E. Reliabili y and alidi y o he
In e na ional physical ac i i y ques ionnai e in he No d- T øndelag
heal h s udy (Hun ) popula ion o men. BMC Med Res Me hodol
2008;8:1–9.
53 Ma ínez- González Miguel Ángel, Co ella D, Salas- Sal adó J, e al.
Coho p o ile: design and me hods o he PREDIMED s udy. In J
Epidemiol 2012;41:377–85.
54 Sch öde H, Fi ó M, Es uch R, e al. A sho sc eene is alid o
assessing Medi e anean die adhe ence among olde Spanish men
and women. J Nu 2011;141:1140–5.
55 Buysse DJ, Reynolds CF, Monk TH, e al. The Pi sbu gh sleep
quali y index: a new ins umen o psychia ic p ac ice and esea ch.
Psychia y Res 1989;28:193–213.
56 Royuela Rico A, Macías Fe nández JA. P opiedades clinimé icas de
la e sión cas ellana del Cues iona io de Pi sbu gh. Vigilia- Sueño,
1997.
57 She e M, Maddux JE, Me candan e B, e al. The sel - e icacy scale:
cons uc ion and alida ion. Psychol Rep 1982.
58 Hibba d JH, S ocka d J, Mahoney ER, e al. De elopmen o
he pa ien ac i a ion measu e (PAM): Concep ualizing and
measu ing ac i a ion in pa ien s and consume s. Heal h Se Res
2004;39:1005–26.
59 An ono sky A. The s uc u e and p ope ies o he sense o
cohe ence scale. Soc Sci Med 1993.
60 Sø ensen K, Pelikan JM, Rö hlin F, e al. Heal h li e acy in Eu ope:
compa a i e esul s o he Eu opean heal h li e acy su ey (HLS- EU).
Eu J Public Heal h 2015;25:1053–8.
61 Guile a G, Ba ios M, Penelo E, e al. Valida ion o he Spanish
e sion o he i a ional p oc as ina ion scale (iPS). PLoS One
2018;13:e0190806.
62 López- To ecillas F, Ga cía J, Cañadas GA, e al. Validi y o
sel - e icacy scale sco es o a Spanish sample. Psychol Rep
2006;98:437–50.
63 Mo eno Chico C, González de Paz L, Mon o e Royo C, e al.
Galla e nández puebla A. Adap ación y alidación de la escala de
e aluación de la ac i ación “Pa ien Ac i a ion Measu e 13” (PAM13)
en una mues a de pacien es c ónicos isi ados en CAP Rambla de
Mú uaTe assa. XXIV P emi d’in e me ia 2018;2018.
64 Mo eno B, Alonso M, Ál a éz E. Sen ido de cohe encia,
pe sonalidad esis en e, au oes ima Y salud. Re Psicol la salud
1997;9:115–37.
65 Nolasco A, Ba ona C, Tamayo- Fonseca N, e al. Heal h li e acy:
psychome ic beha iou o he HLS- EU- Q16 ques ionnai e. Gac
Sani [In e ne ] 2018:8–11.
66 A ousal SP. A oidan and decisional p oc as ina o s: do hey exis ?
Pe s Indi id Di 2010.
67 IBM Co p. Released. IBM SPSS s a is ics e sion 25.0, 2017.
68 R Co e Team. R: a language and en i onmen o s a is ical
compu ing, 2019.
69 Schulz KF, Al man DC, Mohe D. Conso 2010 s a emen : upda ed
guidelines o epo ing pa allel g oup andomised ials. I al J Public
Heal h 2010.
70 Van Hou BA, MJ A, Go don GS, e al. And C/E‐ a ios alongside a
clinical ial. Heal h Econ 1994;3:309–19.
71 Rome o- Sanchiz P, Noguei a- A jona R, Ga cía- Ruiz A, e al.
Economic e alua ion o a guided and unguided In e ne - based CBT
in e en ion o majo dep ession: esul s om a mul i- cen e , h ee-
a med andomized con olled ial conduc ed in p ima y ca e. PLoS
One 2017;12:e0172741.
72 Oblikue Consul ing. Oblikue Da abase [online]. A ailable: h p://www.
oblikue. com/ bddcos es/ [Accessed 29 Oc 2019].
73 Buu en S, G oo huis- Oudshoo n K. Mice: mul i a ia e impu a ion by
Chained. J S a So w 2011.
74 Smi hson S, Pignone MP. Sc eening adul s o dep ession in p ima y
ca e. Med Clin No h Am 2017;101:807–21.
75 C a en MA, Bland R. Dep ession in p ima y ca e: cu en and u u e
challenges. Can J Psychia y 2013;58:442–8.
76 Pence BW, O’Donnell JK, Gaynes BN. The dep ession ea men
cascade in p ima y ca e: a public heal h pe spec i e. Cu Psychia y
Rep 2012;14:328–35.
77 Nieuwsma JA, T i edi RB, McDu ie J, e al. B ie psycho he apy o
dep ession: a sys ema ic e iew and me a- analysis. In J Psychia y
Med 2012;43:129–51.
78 Pipe WE. Unde u iliza ion o sho - e m g oup he apy: enigma ic o
unde s andable? Psycho he apy Resea ch 2008;18:127–38.
79 Simmonds- Buckley M, Kelle S, Walle G. Accep abili y and e icacy
o g oup beha io al ac i a ion o dep ession among adul s: a me a-
analysis. Beha The 2019;50:864–85.
P o ec ed by copy igh . on Feb ua y 2, 2021 a Uni e sidad de Za agoza. Biblio eca.h p://bmjopen.bmj.com/BMJ Open: i s published as 10.1136/bmjopen-2020-038457 on 28 Decembe 2020. Downloaded om